Clinical trial
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in…
NCT00164281 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00164281 |
|---|---|
| Title | Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana |
| Official title | A Randomized, Placebo-Controlled Study of Limited vs. Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Botswana Ministry of Health United States Agency for International Development (USAID) U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tuberculosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Isoniazid |
| Enrollment | 2,000 |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 1, 2009 |
| Completion | May 1, 2011 |
| First posted | Sep 14, 2005 |
| Last update posted | Feb 6, 2014 |
| Countries | Botswana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: